Will any regulator grant emergency authorization to a hantavirus vaccine in 2026?
Pfizer's COVID vaccine got UK MHRA EUA on 2 Dec 2020 — 11 months after the genome was published. Tracks FDA EUA, EMA CMA, MHRA EUA, NMPA emergency use, or PMDA SAKIGAKE for any hantavirus vaccine in 2026.
Resolves YES if any major regulator (FDA, EMA, MHRA, NMPA, PMDA, Health Canada, TGA) issues emergency or conditional authorization for a hantavirus-targeting vaccine before 2026-12-31.
On settlement the oracle attaches a signed snapshot of each source URL plus a SHA-256 hash of the page content captured at resolution time. Disputes have a 7-day arbitration window.
cited: FDA / EMA / MHRA / NMPA / PMDA bulletins + ClinicalTrials.gov
Resolution sources · 4
v2 API returns JSON. Resolves the vaccine-Phase-2 market. Filter `statusModule.overallStatus` and `phase`.
No JSON API; scrape result table.
Wire-grade source; resolves the NYT/major-media markets.
Same role as Reuters; AP often publishes WHO embargoes first.
ETL workers poll these feeds and merge into the resolution oracle.full registry